Galderma Group AG
SIX:GALD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
73.2
163.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of GALD.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
| US |
R
|
Reddit Inc
NYSE:RDDT
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
|
| US |
|
Symbotic Inc
NASDAQ:SYM
|
|
| ID |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Galderma Group AG
Balance Sheet Decomposition
Galderma Group AG
| Current Assets | 1.8B |
| Cash & Short-Term Investments | 457m |
| Receivables | 905m |
| Other Current Assets | 481m |
| Non-Current Assets | 10.8B |
| Long-Term Investments | 1m |
| PP&E | 577m |
| Intangibles | 10B |
| Other Non-Current Assets | 238m |
| Current Liabilities | 1.5B |
| Accounts Payable | 571m |
| Accrued Liabilities | 586m |
| Short-Term Debt | 3m |
| Other Current Liabilities | 368m |
| Non-Current Liabilities | 3.3B |
| Long-Term Debt | 2.7B |
| Other Non-Current Liabilities | 576m |
Free Cash Flow Analysis
Galderma Group AG
| Free Cash Flow |
Earnings Waterfall
Galderma Group AG
|
Revenue
|
4.7B
|
|
Cost of Revenue
|
-1.4B
|
|
Gross Profit
|
3.2B
|
|
Operating Expenses
|
-2.5B
|
|
Operating Income
|
755m
|
|
Other Expenses
|
-377m
|
|
Net Income
|
378m
|
GALD Profitability Score
Profitability Due Diligence
Galderma Group AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Galderma Group AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.
GALD Solvency Score
Solvency Due Diligence
Galderma Group AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Galderma Group AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GALD Price Targets Summary
Galderma Group AG
According to Wall Street analysts, the average 1-year price target for GALD is 159.12 CHF with a low forecast of 131.3 CHF and a high forecast of 193.2 CHF.
Dividends
Current shareholder yield for GALD is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?